Examining Engagement Trends Among Participants in Peripheral Neuropathy Clinical Research

Starting soon

Conditions studied: Peripheral Neuropathy

In brief

This trial aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in peripheral neuropathy clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors. Ultimately, this trial endeavors to deepen our understanding of the factors impacting peripheral neuropathy clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.

Key facts

Study ID

NCT06338384

Run by

Power Life Sciences Inc.

People needed

500

Starts

2025-04-01

Expected to finish

2027-04-01

Last updated by the study team

2024-03-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged ≥ 18 years old
• Diagnosis of peripheral neuropathy
• Able to comprehend the investigational nature of the protocol and provide informed consent

You may not qualify if…

• Female patients who are currently pregnant or nursing
• Inability to perform regular electronic reporting
• Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.